Alternate Day Micafungin: A PK Study in Pediatric Patients

Completed · Phase 1

Conditions studied: Fungal Infection

In brief

The purpose of this study is to examine the pharmacokinetics of micafungin when it is given on an every other day schedule. The study will determine if every other day micafungin will provide drug exposure equivalent to daily dosing while reducing administration costs and improving patient convenience. Fifteen patients will be enrolled on this study. Blood samples for PK measurements will be obtained for 48 hours following a single dose of micafungin (3 mg/kg).

Key facts

Study ID
NCT00842504
Run by
Children's Hospital Medical Center, Cincinnati
People needed
15
Starts
2007-07-01
Expected to finish
2009-12-01
Last updated by the study team
2012-02-16

Who can join

Age: 0 and older, up to 10. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.